Article
Decreased Platelet Inhibition by Thienopyridines in Hyperuricemia.
Cardiovascular drugs and therapy - 1 Feb 2021
Lee Silvia, Wadowski Patricia P, Hoberstorfer Timothy, Weikert Constantin, Pultar Joseph, Kopp Christoph W, Panzer Simon, Gremmel Thomas
Abstract excerpt
PURPOSE: Hyperuricemia carries an increased risk of atherothrombotic events in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). This may at least in part be due to inadequate P2Y12 inhibition. The aim of this study was to prospectively investigate the potential association between hyperuricemia and decreased platelet inhibition by P2Y12 antagonists. METHODS: Levels of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.